| Affiliation: | 1. Stanford University, Palo Alto, CA, USA;2. The Mount Sinai School of Medicine, New York, USA;3. Addenbrooke''s Hospital, Cambridge, UK;4. Charles University and General University Hospital, Prague, Czech Republic;5. Salford Royal Hospital Foundation Trust, Salford, UK;6. Hôpital Necker-Enfants Malades, Paris, France;7. Royal Manchester Children''s Hospital, Manchester, UK;8. Synageva BioPharma, Lexington, MA, USA;1. Interventional Radiology Unit with Integrated Section of Transational Medical Oncology National Cancer Research Centre, Cancer Institute“Giovanni Paolo II”, Bari, Italy;2. Department of Emergencies and Organ Transplantation (DETO)-University of Bari “Aldo Moro”, Italy;3. Department of Biomedical Sciences and Human Oncology, Section of Internal Medicine and Clinical Oncology, University of Bari Medical School, Bari, Italy;4. Department of Prevention and Animal Ealth, ASL BAT, Barletta, Italy;1. Department of Immunology, Genetics & Pathology, Rudbeck Laboratory Uppsala University, 751 85 Uppsala, Sweden;2. Immune and Gene Therapy Laboratory, Department of Oncology and Pathology, Cancer Center Karolinska R8:01, Karolinska Institute, 171 76 Stockholm, Sweden;3. Cyto Pulse Sciences Inc., Glen Burnie, MD, USA;4. Department of Radiology, Oncology and Radiation Science, Uppsala University, Uppsala, Sweden;5. Department of Oncology, Uppsala University Hospital, Uppsala, Sweden;6. Eurocine Vaccines AB, Fogdevreten 2, Karolinska Institutet Science Park, 171 65 Solna, Sweden;7. Roche Glycart AG, Wagistrasse 18, CH-8952 Schlieren, Switzerland;8. Department of Oncology, Karolinska University Hospital, 171 76 Stockholm, Sweden;1. Department of Veterans Affairs Medical Center, Ralph H. Johnson VAMC, Medical University of South Carolina, Charleston, SC, USA;2. Department of Pathology and Laboratory Medicine, Medical University of South Carolina, Charleston, SC, USA;3. Hollings Cancer Center, Medical University of South Carolina, Charleston, SC, USA;1. Department of Haematology, Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia;2. Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Melbourne, VIC, Australia;3. Fourth Department of Internal Medicine–Hematology, University Hospital and Faculty of Medicine, Hradec Kralove, Czech Republic;4. Department of Lymphoma and Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX, USA;5. Department of Hematology and Oncology, University Hospital Brno, Brno, Czech Republic;6. Masaryk University Faculty of Medicine Brno, Brno, Czech Republic;7. Roswell Park Cancer Institute, Buffalo Park, NY, USA;8. Sarah Cannon Research Institute, Tennessee Oncology, Nashville, TN, USA;9. Genentech, South San Francisco, CA, USA |
